Results per Page:
Dying cells signal the thymus to rebuild
From the Dudakov Lab, Translational Science and Therapeutics Division
Decisions, decisions: factors that impact HCT outcomes in AML
From the Walter Group, Translational Sciences and Therapeutics Division
Mutations remain one-in-a-million after HCT
From the Storb Group, Clinical Research Division
Commensals turn pathogenic in graft-vs-host disease
From the University of Michigan and the Fredricks Lab, Vaccine and Infectious Disease Division